(Q35820367)

English

Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation

scientific article published on 13 May 2015

Statements

Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation (English)
13 May 2015

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit